Alzheimer’s disease (AD): preventative measures
Evidence-based neurology checklist on alzheimer’s disease (ad): preventative measures: Measures with very strong evidence Education Cognitive activity Reduction of high body mass index in late life Treatment of hyperhomocysteinaemia: with folic acid, vitamin B12 and vitamin B6 Treatment of…
Measures with very strong evidence
- Education
- Cognitive activity
- Reduction of high body mass index in late life
- Treatment of hyperhomocysteinaemia: with folic acid, vitamin B12 and vitamin B6
- Treatment of depression
- Stress reduction
- Treatment of diabetes
- Prevention of head trauma
- Controlling mid-life hypertension
- Treat of orthostatic hypotension
Measures with weaker evidence
Measures of uncertain benefit
Measures not recommended
References
- Yu JT, Xu W, Tan CC, et al. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. JNNP 2020 (Online ahead of print).
- Rakesh G, Szabo ST, Alexopoulos GS, Zannas AS. Strategies for dementia prevention: latest evidence and implications. Ther Adv Chronic Dis 2017; 8:121-136.
- Sun M, Chen W-M, Wu S-Y, et al. Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction. Brain 2023 (Online ahead of print).
- López-Ortiz S, Lista S, Valenzuela PL, et al. Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analyses. J Neurol 2023; 270:711-725.
Related checklists
- Alzheimer’s disease (AD): risk factors
- Alzheimer’s disease (AD): protective factors
- Alzheimer’s disease (AD): clinical features
- Alzheimer's Disease (AD) v frontotemporal dementia (FTD)
- Alzheimer’s disease (AD): investigations
- Alzheimer’s disease (AD): emerging investigations
- Alzheimer’s disease (AD): non-drug management
- Alzheimer’s disease (AD): conventional drug treatments
- Alzheimer’s disease (AD): lecanemab treatment
- Alzheimer’s disease (AD): investigational treatments
- Alzheimer’s disease: driving and safety issues